178 related articles for article (PubMed ID: 1776031)
21. Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport.
Buck ML
DICP; 1991 Apr; 25(4):408-9. PubMed ID: 1926911
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the ductus arteriosus in fetuses with tetralogy of Fallot and the implication for postnatal management.
Tuo G; Volpe P; Buffi D; De Robertis V; Marasini M
Congenit Heart Dis; 2014; 9(5):382-90. PubMed ID: 24373413
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
Reddy SC; Saxena A
Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
[TBL] [Abstract][Full Text] [Related]
24. Effect of Long-term Administration of Prostaglandin E
Iwaki R; Matsuhisa H; Minamisawa S; Akaike T; Hoshino M; Yagi N; Morita K; Shinohara G; Kaneko Y; Yoshitake S; Takahashi M; Tsukube T; Oshima Y
Ann Thorac Surg; 2020 Dec; 110(6):2088-2095. PubMed ID: 32246933
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E1-induced periostitis in a neonate with congenital heart disease.
Sá L; Dias SC; Costa AC; Rosário M
Pediatr Int; 2022 Jan; 64(1):e15288. PubMed ID: 36134666
[No Abstract] [Full Text] [Related]
26. Generalized periosteal reaction and tissue swelling secondary to prolonged prostaglandin E1 infusion and venous stasis: a case report.
Alan S; Uçar T; Erdeve O; Atasay B; Arsan S; Atalay S
Turk J Pediatr; 2013; 55(5):543-5. PubMed ID: 24382539
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.
Ringel RE; Brenner JI; Haney PJ; Burns JE; Moulton AL; Berman MA
Radiology; 1982 Mar; 142(3):657-8. PubMed ID: 7199748
[No Abstract] [Full Text] [Related]
29. Aneurysmal change of the ductus arteriosus after prostaglandin E1 administration for pulmonary atresia: demonstration with magnetic resonance imaging.
Tsubata S; Hashimoto I; Ichida F; Miyazaki A; Okada T; Murakami A; Morita H; Fukahara K
Pediatr Cardiol; 1994; 15(1):30-2. PubMed ID: 8115269
[TBL] [Abstract][Full Text] [Related]
30. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
[TBL] [Abstract][Full Text] [Related]
31. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
Ohara T; Ogata H; Fujiyama J; Murata Y; Abe J; Kakuta K; Hayamizu S; Kameyama S; Yoshida Y
Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
[TBL] [Abstract][Full Text] [Related]
32. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
Fernández MA; Gebara E
Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
[TBL] [Abstract][Full Text] [Related]
33. Periosteal reaction induced by prostaglandins.
Niethammer JG; Rule KA; Lorch V; Anderson ME
Am J Perinatol; 1992 Jul; 9(4):279-80. PubMed ID: 1627219
[TBL] [Abstract][Full Text] [Related]
34. [Prostaglandin-induced periostitis].
Nakagawa T; Hamada S; Nishiki T; Yamamoto I; Tachi K; Takahashi H
Rinsho Hoshasen; 1983 Jun; 28(6):715-8. PubMed ID: 6684701
[No Abstract] [Full Text] [Related]
35. Congenital Eyelid Imbrication and Floppy Eyelid Syndromes Complicated by Eversion due to Prostaglandin E Infusion in a Patient With Trisomy 21 and Tetralogy of Fallot.
Strong Caldwell A; Volkin J; Wu T; Vloka C; Hink E
Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):e82-e83. PubMed ID: 38231660
[TBL] [Abstract][Full Text] [Related]
36. The impact of not having a ductus arteriosus on clinical outcomes in foetuses diagnosed with tetralogy of Fallot.
Stern SJ; Wadekar N; Mertens L; Manlhiot C; McCrindle BW; Jaeggi ET; Nield LE
Cardiol Young; 2015 Apr; 25(4):684-92. PubMed ID: 24775715
[TBL] [Abstract][Full Text] [Related]
37. Histopathology of the ductus arteriosus after PGE1 treatment.
Gittenberger-de Groot AC
Pediatr Cardiol; 1995; 16(2):101. PubMed ID: 7784233
[No Abstract] [Full Text] [Related]
38. Aminophylline for the prevention of apnea during prostaglandin E1 infusion.
Lim DS; Kulik TJ; Kim DW; Charpie JR; Crowley DC; Maher KO
Pediatrics; 2003 Jul; 112(1 Pt 1):e27-9. PubMed ID: 12837902
[TBL] [Abstract][Full Text] [Related]
39. Responsiveness of the ductus arteriosus to prostaglandin E1 assessed by combined cross sectional and pulsed Doppler echocardiography.
Hiraishi S; Fujino N; Saito K; Oguchi K; Kadoi N; Agata Y; Horiguchi Y; Hozumi H; Yashiro K
Br Heart J; 1989 Aug; 62(2):140-7. PubMed ID: 2765326
[TBL] [Abstract][Full Text] [Related]
40. [Clinical picture and diagnosis of patent ductus arteriosus with tetralogy of Fallot].
ZARGARLI FI
Pediatriia; 1958 Jul; 22(7):19-22. PubMed ID: 13590861
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
